Defining the role of radiofrequency ablation and stereotactic ablative radiotherapy in patients with high-risk, early-stage non-small cell lung cancer

Alexander V. Louie; Shankar Siva; Suresh Senan

doi:10.1002/cncr.29698

Defining the role of radiofrequency ablation and stereotactic ablative radiotherapy in patients with high-risk, early-stage non-small cell lung cancer

Alexander V. Louie, Shankar Siva, Suresh Senan

Radiation Oncology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	322-323
Journal	Cancer
Volume	122
Issue number	2
DOIs	https://doi.org/10.1002/cncr.29698
Publication status	Published - 15 Jan 2016

Access to Document

10.1002/cncr.29698

Cite this

@article{167596bb109349a789395a8d9ab2b6f0,

title = "Defining the role of radiofrequency ablation and stereotactic ablative radiotherapy in patients with high-risk, early-stage non-small cell lung cancer",

author = "Louie, {Alexander V.} and Shankar Siva and Suresh Senan",

year = "2016",

month = jan,

day = "15",

doi = "10.1002/cncr.29698",

language = "English",

volume = "122",

pages = "322--323",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "2",

}

TY - JOUR

T1 - Defining the role of radiofrequency ablation and stereotactic ablative radiotherapy in patients with high-risk, early-stage non-small cell lung cancer

AU - Louie, Alexander V.

AU - Siva, Shankar

AU - Senan, Suresh

PY - 2016/1/15

Y1 - 2016/1/15

U2 - 10.1002/cncr.29698

DO - 10.1002/cncr.29698

M3 - Article

C2 - 26421800

VL - 122

SP - 322

EP - 323

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 2

ER -